A co-dominant genetic model was fitted for APOC3 sites −482, −455 and 3238, and in all cases we found lower hypercholesterolemia risk for heterozygous individuals than for patients without the minor allele under a PI-based regimen boosted with RTV. Here, APOC3 is linked to familial hypercholesterolemia.